APO Research

APO RESEARCH · REPORT

Glycomacropeptide (GMP) Supplements

Selected research

Industry Growth & Trends

Global Glycomacropeptide (GMP) Supplements Industry Growth and Trends Forecast to 2032

Market perspective

The global Glycomacropeptide (GMP) Supplements market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Glycomacropeptide (GMP) Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Glycomacropeptide (GMP) Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glycomacropeptide (GMP) Supplements is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glycomacropeptide (GMP) Supplements include Right Food, Nestlé Health Science, MET-Rx Nutrition Inc, Glanbia, Plc., Benfatto Nutrition, Arla Foods, AMCO Proteins and Agropur Coopérative, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Glycomacropeptide (GMP) Supplements market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Glycomacropeptide (GMP) Supplements market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Glycomacropeptide (GMP) Supplements market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Glycomacropeptide (GMP) Supplements.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Glycomacropeptide (GMP) Supplements market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Glycomacropeptide (GMP) Supplements Market by Company

Right Food

Nestlé Health Science

MET-Rx Nutrition Inc

Glanbia, Plc.

Benfatto Nutrition

Arla Foods

AMCO Proteins

Agropur Coopérative

Glycomacropeptide (GMP) Supplements Segment by Type

Glycomacropeptide Supplements For Adults

Glycomacropeptide Supplements For Children

Glycomacropeptide (GMP) Supplements Segment by Application

Hypermarket/Supermarket

Online Stores

Medical Stores

Specialty Stores

Other

Glycomacropeptide (GMP) Supplements Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycomacropeptide (GMP) Supplements market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glycomacropeptide (GMP) Supplements and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycomacropeptide (GMP) Supplements.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glycomacropeptide (GMP) Supplements manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Glycomacropeptide (GMP) Supplements in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Glycomacropeptide Supplements For Adults Table 2. Major Company of Glycomacropeptide Supplements For Children Table 3. Global Glycomacropeptide (GMP) Supplements Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Glycomacropeptide (GMP) Supplements Sales by Type (2021-2026) & (Tons) Table 5. Global Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Type (2021-2026) Table 6. Global Glycomacropeptide (GMP) Supplements Sales by Type (2021-2026) & (US$ Million) Table 7. Global Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Type (2021-2026) Table 8. Global Glycomacropeptide (GMP) Supplements Price by Type (2021-2026) & (US$/Ton) Table 9. Global Glycomacropeptide (GMP) Supplements Sales by Type (2027-2032) & (Tons) Table 10. Global Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Type (2027-2032) Table 11. Global Glycomacropeptide (GMP) Supplements Sales by Type (2027-2032) & (US$ Million) Table 12. Global Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Type (2027-2032) Table 13. Global Glycomacropeptide (GMP) Supplements Price by Type (2027-2032) & (US$/Ton) Table 14. North America Glycomacropeptide (GMP) Supplements Sales by Type (2021-2026) & (Tons) Table 15. North America Glycomacropeptide (GMP) Supplements Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Glycomacropeptide (GMP) Supplements Sales by Type (2021-2026) & (Tons) Table 17. Europe Glycomacropeptide (GMP) Supplements Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales by Type (2021-2026) & (Tons) Table 19. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Glycomacropeptide (GMP) Supplements Sales by Type (2021-2026) & (Tons) Table 21. Latin America Glycomacropeptide (GMP) Supplements Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales by Type (2021-2026) & (Tons) Table 23. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales by Type (2021-2026) & (US$ Million) Table 24. Glycomacropeptide (GMP) Supplements Industry Trends Table 25. Glycomacropeptide (GMP) Supplements Industry Drivers Table 26. Glycomacropeptide (GMP) Supplements Industry Opportunities and Challenges Table 27. Glycomacropeptide (GMP) Supplements Industry Restraints Table 28. Global Glycomacropeptide (GMP) Supplements Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Glycomacropeptide (GMP) Supplements Revenue Market Share by Company (2021-2026) Table 30. Global Glycomacropeptide (GMP) Supplements Sales by Company (2021-2026) & (Tons) Table 31. Global Glycomacropeptide (GMP) Supplements Sales Share by Company (2021-2026) Table 32. Global Glycomacropeptide (GMP) Supplements Market Price by Company (2021-2026) & (US$/Ton) Table 33. Global Glycomacropeptide (GMP) Supplements Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Glycomacropeptide (GMP) Supplements Major Company Production Sites and Headquarters Table 35. Global Glycomacropeptide (GMP) Supplements Company, Product Type & Application Table 36. Global Glycomacropeptide (GMP) Supplements Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Glycomacropeptide (GMP) Supplements by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Glycomacropeptide (GMP) Supplements Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Glycomacropeptide (GMP) Supplements Sales by Region (2021-2026) & (Tons) Table 41. Global Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Region (2021-2026) Table 42. Global Glycomacropeptide (GMP) Supplements Sales by Region (2021-2026) & (US$ Million) Table 43. Global Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Region (2021-2026) Table 44. Global Glycomacropeptide (GMP) Supplements Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 45. Global Glycomacropeptide (GMP) Supplements Sales by Region (2027-2032) & (Tons) Table 46. Global Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Region (2027-2032) Table 47. Global Glycomacropeptide (GMP) Supplements Sales by Region (2027-2032) & (US$ Million) Table 48. Global Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Region (2027-2032) Table 49. Global Glycomacropeptide (GMP) Supplements Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 50. Global Glycomacropeptide (GMP) Supplements Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Glycomacropeptide (GMP) Supplements Sales by Application (2021-2026) & (Tons) Table 52. Global Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Application (2021-2026) Table 53. Global Glycomacropeptide (GMP) Supplements Sales by Application (2021-2026) & (US$ Million) Table 54. Global Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Application (2021-2026) Table 55. Global Glycomacropeptide (GMP) Supplements Price by Application (2021-2026) & (US$/Ton) Table 56. Global Glycomacropeptide (GMP) Supplements Sales by Application (2027-2032) & (Tons) Table 57. Global Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Application (2027-2032) Table 58. Global Glycomacropeptide (GMP) Supplements Sales by Application (2027-2032) & (US$ Million) Table 59. Global Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Application (2027-2032) Table 60. Global Glycomacropeptide (GMP) Supplements Price by Application (2027-2032) & (US$/Ton) Table 61. North America Glycomacropeptide (GMP) Supplements Sales by Application (2021-2026) & (Tons) Table 62. North America Glycomacropeptide (GMP) Supplements Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Glycomacropeptide (GMP) Supplements Sales by Application (2021-2026) & (Tons) Table 64. Europe Glycomacropeptide (GMP) Supplements Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales by Application (2021-2026) & (Tons) Table 66. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Glycomacropeptide (GMP) Supplements Sales by Application (2021-2026) & (Tons) Table 68. Latin America Glycomacropeptide (GMP) Supplements Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales by Application (2021-2026) & (Tons) Table 70. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales by Application (2021-2026) & (US$ Million) Table 71. Right Food Company Information Table 72. Right Food Business Overview Table 73. Right Food Glycomacropeptide (GMP) Supplements Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 74. Right Food Glycomacropeptide (GMP) Supplements Product Portfolio Table 75. Right Food Recent Development Table 76. Nestlé Health Science Company Information Table 77. Nestlé Health Science Business Overview Table 78. Nestlé Health Science Glycomacropeptide (GMP) Supplements Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 79. Nestlé Health Science Glycomacropeptide (GMP) Supplements Product Portfolio Table 80. Nestlé Health Science Recent Development Table 81. MET-Rx Nutrition Inc Company Information Table 82. MET-Rx Nutrition Inc Business Overview Table 83. MET-Rx Nutrition Inc Glycomacropeptide (GMP) Supplements Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 84. MET-Rx Nutrition Inc Glycomacropeptide (GMP) Supplements Product Portfolio Table 85. MET-Rx Nutrition Inc Recent Development Table 86. Glanbia, Plc. Company Information Table 87. Glanbia, Plc. Business Overview Table 88. Glanbia, Plc. Glycomacropeptide (GMP) Supplements Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 89. Glanbia, Plc. Glycomacropeptide (GMP) Supplements Product Portfolio Table 90. Glanbia, Plc. Recent Development Table 91. Benfatto Nutrition Company Information Table 92. Benfatto Nutrition Business Overview Table 93. Benfatto Nutrition Glycomacropeptide (GMP) Supplements Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 94. Benfatto Nutrition Glycomacropeptide (GMP) Supplements Product Portfolio Table 95. Benfatto Nutrition Recent Development Table 96. Arla Foods Company Information Table 97. Arla Foods Business Overview Table 98. Arla Foods Glycomacropeptide (GMP) Supplements Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 99. Arla Foods Glycomacropeptide (GMP) Supplements Product Portfolio Table 100. Arla Foods Recent Development Table 101. AMCO Proteins Company Information Table 102. AMCO Proteins Business Overview Table 103. AMCO Proteins Glycomacropeptide (GMP) Supplements Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 104. AMCO Proteins Glycomacropeptide (GMP) Supplements Product Portfolio Table 105. AMCO Proteins Recent Development Table 106. Agropur Coopérative Company Information Table 107. Agropur Coopérative Business Overview Table 108. Agropur Coopérative Glycomacropeptide (GMP) Supplements Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 109. Agropur Coopérative Glycomacropeptide (GMP) Supplements Product Portfolio Table 110. Agropur Coopérative Recent Development Table 111. North America Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 112. North America Glycomacropeptide (GMP) Supplements Sales by Country (2021-2026) & (Tons) Table 113. North America Glycomacropeptide (GMP) Supplements Sales Market Share by Country (2021-2026) Table 114. North America Glycomacropeptide (GMP) Supplements Sales Forecast by Country (2027-2032) & (Tons) Table 115. North America Glycomacropeptide (GMP) Supplements Sales Market Share Forecast by Country (2027-2032) Table 116. North America Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Glycomacropeptide (GMP) Supplements Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Glycomacropeptide (GMP) Supplements Market Share by Country (2021-2026) Table 119. North America Glycomacropeptide (GMP) Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Glycomacropeptide (GMP) Supplements Market Share Forecast by Country (2027-2032) Table 121. Europe Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 122. Europe Glycomacropeptide (GMP) Supplements Sales by Country (2021-2026) & (Tons) Table 123. Europe Glycomacropeptide (GMP) Supplements Sales Market Share by Country (2021-2026) Table 124. Europe Glycomacropeptide (GMP) Supplements Sales Forecast by Country (2027-2032) & (Tons) Table 125. Europe Glycomacropeptide (GMP) Supplements Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Glycomacropeptide (GMP) Supplements Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Glycomacropeptide (GMP) Supplements Market Share by Country (2021-2026) Table 129. Europe Glycomacropeptide (GMP) Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Glycomacropeptide (GMP) Supplements Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales by Country (2021-2026) & (Tons) Table 133. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales Forecast by Country (2027-2032) & (Tons) Table 135. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Glycomacropeptide (GMP) Supplements Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Glycomacropeptide (GMP) Supplements Market Share by Country (2021-2026) Table 139. Asia-Pacific Glycomacropeptide (GMP) Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Glycomacropeptide (GMP) Supplements Market Share Forecast by Country (2027-2032) Table 141. Latin America Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 142. Latin America Glycomacropeptide (GMP) Supplements Sales by Country (2021-2026) & (Tons) Table 143. Latin America Glycomacropeptide (GMP) Supplements Sales Market Share by Country (2021-2026) Table 144. Latin America Glycomacropeptide (GMP) Supplements Sales Forecast by Country (2027-2032) & (Tons) Table 145. Latin America Glycomacropeptide (GMP) Supplements Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Glycomacropeptide (GMP) Supplements Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Glycomacropeptide (GMP) Supplements Market Share by Country (2021-2026) Table 149. Latin America Glycomacropeptide (GMP) Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Glycomacropeptide (GMP) Supplements Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales by Country (2021-2026) & (Tons) Table 153. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales Forecast by Country (2027-2032) & (Tons) Table 155. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Glycomacropeptide (GMP) Supplements Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Glycomacropeptide (GMP) Supplements Market Share by Country (2021-2026) Table 159. Middle East and Africa Glycomacropeptide (GMP) Supplements Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Glycomacropeptide (GMP) Supplements Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Glycomacropeptide (GMP) Supplements Distributors List Table 164. Glycomacropeptide (GMP) Supplements Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Glycomacropeptide (GMP) Supplements Image Figure 2. Global Glycomacropeptide (GMP) Supplements Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glycomacropeptide (GMP) Supplements Market Size (2021-2032) & (US$ Million) Figure 4. Global Glycomacropeptide (GMP) Supplements Sales (2021-2032) & (Tons) Figure 5. Glycomacropeptide Supplements For Adults Image Figure 6. Global Glycomacropeptide Supplements For Adults Sales YoY Growth (2021-2032) & (Tons) Figure 7. Glycomacropeptide Supplements For Children Image Figure 8. Global Glycomacropeptide Supplements For Children Sales YoY Growth (2021-2032) & (Tons) Figure 9. Global Glycomacropeptide (GMP) Supplements Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Glycomacropeptide (GMP) Supplements Market Share by Type 2025 VS 2032 Figure 11. North America Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Type in 2025 Figure 12. North America Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Type in 2025 Figure 13. Europe Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Type in 2025 Figure 14. Europe Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Type in 2025 Figure 17. Latin America Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Glycomacropeptide (GMP) Supplements Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hypermarket/Supermarket Image Figure 24. Global Hypermarket/Supermarket Sales YoY Growth (2021-2032) & (Tons) Figure 25. Online Stores Image Figure 26. Global Online Stores Sales YoY Growth (2021-2032) & (Tons) Figure 27. Medical Stores Image Figure 28. Global Medical Stores Sales YoY Growth (2021-2032) & (Tons) Figure 29. Specialty Stores Image Figure 30. Global Specialty Stores Sales YoY Growth (2021-2032) & (Tons) Figure 31. Other Image Figure 32. Global Other Sales YoY Growth (2021-2032) & (Tons) Figure 33. Global Glycomacropeptide (GMP) Supplements Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Glycomacropeptide (GMP) Supplements Market Share by Application 2025 VS 2032 Figure 35. North America Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Application in 2025 Figure 36. North America Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Application in 2025 Figure 37. Europe Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Application in 2025 Figure 38. Europe Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Application in 2025 Figure 41. Latin America Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales Market Share in Value by Application in 2025 Figure 45. North America Glycomacropeptide (GMP) Supplements Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 46. North America Glycomacropeptide (GMP) Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Glycomacropeptide (GMP) Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Glycomacropeptide (GMP) Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Glycomacropeptide (GMP) Supplements Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 50. Europe Glycomacropeptide (GMP) Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Glycomacropeptide (GMP) Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Glycomacropeptide (GMP) Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 54. Asia-Pacific Glycomacropeptide (GMP) Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Glycomacropeptide (GMP) Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Glycomacropeptide (GMP) Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Glycomacropeptide (GMP) Supplements Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 58. Latin America Glycomacropeptide (GMP) Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Glycomacropeptide (GMP) Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Glycomacropeptide (GMP) Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 62. Middle East and Africa Glycomacropeptide (GMP) Supplements Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Glycomacropeptide (GMP) Supplements Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Glycomacropeptide (GMP) Supplements Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Glycomacropeptide (GMP) Supplements Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Glycomacropeptide (GMP) Supplements Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Glycomacropeptide Supplements For Adults
  • Glycomacropeptide Supplements For Children
Applications
  • Hypermarket/Supermarket
  • Online Stores
  • Medical Stores
  • Specialty Stores
  • Other
Companies covered
  • Right Food
  • Nestlé Health Science
  • MET-Rx Nutrition Inc
  • Glanbia, Plc.
  • Benfatto Nutrition
  • Arla Foods
  • AMCO Proteins
  • Agropur Coopérative

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Glycomacropeptide (GMP) Supplements Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Glycomacropeptide (GMP) Supplements Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Glycomacropeptide (GMP) Supplements Market by Type
  6. 1.3.1 Glycomacropeptide Supplements For Adults
  7. 1.3.2 Glycomacropeptide Supplements For Children
  8. 1.4 Global Glycomacropeptide (GMP) Supplements Market Size by Type
  9. 1.4.1 Global Glycomacropeptide (GMP) Supplements Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Glycomacropeptide (GMP) Supplements Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Glycomacropeptide (GMP) Supplements Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Glycomacropeptide (GMP) Supplements Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Glycomacropeptide (GMP) Supplements Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Glycomacropeptide (GMP) Supplements Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Glycomacropeptide (GMP) Supplements Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Glycomacropeptide (GMP) Supplements Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Glycomacropeptide (GMP) Supplements Industry Trends
  2. 2.2 Glycomacropeptide (GMP) Supplements Industry Drivers
  3. 2.3 Glycomacropeptide (GMP) Supplements Industry Opportunities and Challenges
  4. 2.4 Glycomacropeptide (GMP) Supplements Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Glycomacropeptide (GMP) Supplements Revenue (2021-2026)
  2. 3.2 Global Top Players by Glycomacropeptide (GMP) Supplements Sales (2021-2026)
  3. 3.3 Global Top Players by Glycomacropeptide (GMP) Supplements Price (2021-2026)
  4. 3.4 Global Glycomacropeptide (GMP) Supplements Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glycomacropeptide (GMP) Supplements Major Company Production Sites & Headquarters
  6. 3.6 Global Glycomacropeptide (GMP) Supplements Company, Product Type & Application
  7. 3.7 Global Glycomacropeptide (GMP) Supplements Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glycomacropeptide (GMP) Supplements Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glycomacropeptide (GMP) Supplements Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glycomacropeptide (GMP) Supplements Tier 1, Tier 2, and Tier 3
4 Glycomacropeptide (GMP) Supplements Regional Status and Outlook
  1. 4.1 Global Glycomacropeptide (GMP) Supplements Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Glycomacropeptide (GMP) Supplements Historic Market Size by Region
  3. 4.2.1 Global Glycomacropeptide (GMP) Supplements Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Glycomacropeptide (GMP) Supplements Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Glycomacropeptide (GMP) Supplements Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Glycomacropeptide (GMP) Supplements Forecasted Market Size by Region
  7. 4.3.1 Global Glycomacropeptide (GMP) Supplements Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Glycomacropeptide (GMP) Supplements Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Glycomacropeptide (GMP) Supplements Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Glycomacropeptide (GMP) Supplements by Application
  1. 5.1 Glycomacropeptide (GMP) Supplements Market by Application
  2. 5.1.1 Hypermarket/Supermarket
  3. 5.1.2 Online Stores
  4. 5.1.3 Medical Stores
  5. 5.1.4 Specialty Stores
  6. 5.1.5 Other
  7. 5.2 Global Glycomacropeptide (GMP) Supplements Market Size by Application
  8. 5.2.1 Global Glycomacropeptide (GMP) Supplements Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Glycomacropeptide (GMP) Supplements Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Glycomacropeptide (GMP) Supplements Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Glycomacropeptide (GMP) Supplements Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Glycomacropeptide (GMP) Supplements Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Glycomacropeptide (GMP) Supplements Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Glycomacropeptide (GMP) Supplements Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Glycomacropeptide (GMP) Supplements Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Right Food
  2. 6.1.1 Right Food Company Information
  3. 6.1.2 Right Food Business Overview
  4. 6.1.3 Right Food Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Right Food Glycomacropeptide (GMP) Supplements Product Portfolio
  6. 6.1.5 Right Food Recent Developments
  7. 6.2 Nestlé Health Science
  8. 6.2.1 Nestlé Health Science Company Information
  9. 6.2.2 Nestlé Health Science Business Overview
  10. 6.2.3 Nestlé Health Science Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Nestlé Health Science Glycomacropeptide (GMP) Supplements Product Portfolio
  12. 6.2.5 Nestlé Health Science Recent Developments
  13. 6.3 MET-Rx Nutrition Inc
  14. 6.3.1 MET-Rx Nutrition Inc Company Information
  15. 6.3.2 MET-Rx Nutrition Inc Business Overview
  16. 6.3.3 MET-Rx Nutrition Inc Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 MET-Rx Nutrition Inc Glycomacropeptide (GMP) Supplements Product Portfolio
  18. 6.3.5 MET-Rx Nutrition Inc Recent Developments
  19. 6.4 Glanbia, Plc.
  20. 6.4.1 Glanbia, Plc. Company Information
  21. 6.4.2 Glanbia, Plc. Business Overview
  22. 6.4.3 Glanbia, Plc. Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Glanbia, Plc. Glycomacropeptide (GMP) Supplements Product Portfolio
  24. 6.4.5 Glanbia, Plc. Recent Developments
  25. 6.5 Benfatto Nutrition
  26. 6.5.1 Benfatto Nutrition Company Information
  27. 6.5.2 Benfatto Nutrition Business Overview
  28. 6.5.3 Benfatto Nutrition Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Benfatto Nutrition Glycomacropeptide (GMP) Supplements Product Portfolio
  30. 6.5.5 Benfatto Nutrition Recent Developments
  31. 6.6 Arla Foods
  32. 6.6.1 Arla Foods Company Information
  33. 6.6.2 Arla Foods Business Overview
  34. 6.6.3 Arla Foods Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Arla Foods Glycomacropeptide (GMP) Supplements Product Portfolio
  36. 6.6.5 Arla Foods Recent Developments
  37. 6.7 AMCO Proteins
  38. 6.7.1 AMCO Proteins Company Information
  39. 6.7.2 AMCO Proteins Business Overview
  40. 6.7.3 AMCO Proteins Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AMCO Proteins Glycomacropeptide (GMP) Supplements Product Portfolio
  42. 6.7.5 AMCO Proteins Recent Developments
  43. 6.8 Agropur Coopérative
  44. 6.8.1 Agropur Coopérative Company Information
  45. 6.8.2 Agropur Coopérative Business Overview
  46. 6.8.3 Agropur Coopérative Glycomacropeptide (GMP) Supplements Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Agropur Coopérative Glycomacropeptide (GMP) Supplements Product Portfolio
  48. 6.8.5 Agropur Coopérative Recent Developments
7 North America by Country
  1. 7.1 North America Glycomacropeptide (GMP) Supplements Sales by Country
  2. 7.1.1 North America Glycomacropeptide (GMP) Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Glycomacropeptide (GMP) Supplements Sales by Country (2021-2026)
  4. 7.1.3 North America Glycomacropeptide (GMP) Supplements Sales Forecast by Country (2027-2032)
  5. 7.2 North America Glycomacropeptide (GMP) Supplements Market Size by Country
  6. 7.2.1 North America Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Glycomacropeptide (GMP) Supplements Market Size by Country (2021-2026)
  8. 7.2.3 North America Glycomacropeptide (GMP) Supplements Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Glycomacropeptide (GMP) Supplements Sales by Country
  2. 8.1.1 Europe Glycomacropeptide (GMP) Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Glycomacropeptide (GMP) Supplements Sales by Country (2021-2026)
  4. 8.1.3 Europe Glycomacropeptide (GMP) Supplements Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Glycomacropeptide (GMP) Supplements Market Size by Country
  6. 8.2.1 Europe Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Glycomacropeptide (GMP) Supplements Market Size by Country (2021-2026)
  8. 8.2.3 Europe Glycomacropeptide (GMP) Supplements Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Glycomacropeptide (GMP) Supplements Sales by Country
  2. 9.1.1 Asia-Pacific Glycomacropeptide (GMP) Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Glycomacropeptide (GMP) Supplements Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Glycomacropeptide (GMP) Supplements Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Glycomacropeptide (GMP) Supplements Market Size by Country
  6. 9.2.1 Asia-Pacific Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Glycomacropeptide (GMP) Supplements Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Glycomacropeptide (GMP) Supplements Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Glycomacropeptide (GMP) Supplements Sales by Country
  2. 10.1.1 South America Glycomacropeptide (GMP) Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Glycomacropeptide (GMP) Supplements Sales by Country (2021-2026)
  4. 10.1.3 South America Glycomacropeptide (GMP) Supplements Sales Forecast by Country (2027-2032)
  5. 10.2 South America Glycomacropeptide (GMP) Supplements Market Size by Country
  6. 10.2.1 South America Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Glycomacropeptide (GMP) Supplements Market Size by Country (2021-2026)
  8. 10.2.3 South America Glycomacropeptide (GMP) Supplements Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Glycomacropeptide (GMP) Supplements Sales by Country
  2. 11.1.1 Middle East and Africa Glycomacropeptide (GMP) Supplements Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Glycomacropeptide (GMP) Supplements Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Glycomacropeptide (GMP) Supplements Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Glycomacropeptide (GMP) Supplements Market Size by Country
  6. 11.2.1 Middle East and Africa Glycomacropeptide (GMP) Supplements Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Glycomacropeptide (GMP) Supplements Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Glycomacropeptide (GMP) Supplements Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Glycomacropeptide (GMP) Supplements Value Chain Analysis
  2. 12.1.1 Glycomacropeptide (GMP) Supplements Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Glycomacropeptide (GMP) Supplements Production Mode & Process
  7. 12.2 Glycomacropeptide (GMP) Supplements Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Glycomacropeptide (GMP) Supplements Distributors
  10. 12.2.3 Glycomacropeptide (GMP) Supplements Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research